Table 1.
M | Me | SD | Sk. | Kurt. | Min | Max | D | p | |
---|---|---|---|---|---|---|---|---|---|
β-endorphin measurement I | 246.37 | 220.90 | 53.27 | 0.34 | −1.51 | 158.90 | 354.20 | 0.21 | <0.001 |
β-endorphin measurement II | 194.31 | 195.89 | 18.71 | −0.07 | −0.26 | 143.83 | 231.71 | 0.06 | 0.200 |
Serotonin measurement I | 141 | 136.80 | 18.15 | 1.06 | 2.81 | 90.10 | 213.40 | 0.13 | <0.001 |
Serotonin measurement II | 135.24 | 136.70 | 20.36 | 0.19 | 0.01 | 95.40 | 183.40 | 0.09 | 0.167 |
Months to relapse | 16.76 | 17.50 | 5 | −0.10 | 2.49 | 3 | 30 | 0.14 | 0.083 |
Survival months | 32.64 | 36 | 5.48 | −1.88 | 3.34 | 10 | 36 | 0.31 | <0.001 |
M—median; Me—median; SD—standard deviation; Sk.—skewness; Kurt.—kurtosis; Min and Max—lowest and highest value of the distribution; D—the result of the Kolmogorov-Smirnov test; p—significance.